92 filings
Page 3 of 5
8-K
lz662o5dx
14 Nov 22
Icosavax Reports Third Quarter Financial Results and Provides
12:00am
EFFECT
bgnhrj57dsxrb73a5
30 Aug 22
Notice of effectiveness
12:15am
CORRESP
n3v8gbyzm965akcrii
25 Aug 22
Correspondence with SEC
12:00am
UPLOAD
sraxnu4
23 Aug 22
Letter from SEC
12:00am
S-3
nwzzu9576h3bi1hm
15 Aug 22
Shelf registration
6:34pm
8-K
9eg33d5 92e0qa
15 Aug 22
Icosavax Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:40pm
8-K
t5awdpsdcxhv2zu
28 Jun 22
Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate IVX-121 Against RSV
4:10pm
8-K
9zs7eq0db5888
15 Jun 22
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
bem 0veg8h
16 May 22
Icosavax Reports First Quarter 2022 Financial Results and Provides Corporate Update
12:00am
DEFA14A
vnndndhta3rt8up
25 Apr 22
Additional proxy soliciting materials
4:56pm
DEF 14A
veey7xd4n8
25 Apr 22
Definitive proxy
4:53pm
8-K
d88j ti7yg24kya
25 Apr 22
Regulation FD Disclosure
8:01am
10-K
jj5og7o4m
30 Mar 22
Annual report
5:03pm
8-K
4fuvnyp udnzc9u
30 Mar 22
Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:39pm
8-K
6w5zuyvkhx
25 Mar 22
Other Events
8:09am
8-K
mi6s2
11 Feb 22
Departure of Directors or Certain Officers
5:20pm
8-K
5taaifitvg 50ugbrrx
7 Jan 22
Icosavax Provides Corporate Update and Anticipated
8:42am